BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1964978)

  • 1. [Clinical significance of erythrocyte (Na(+)-K+) ATPase activity in the diagnosis of diabetes mellitus and their complications].
    Mimura M; Kanatsuka A; Makino H; Yoshida S
    Nihon Rinsho; 1990 Dec; 48 Suppl():418-25. PubMed ID: 1964978
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythrocyte (Na(+)-K+) ATPase activity].
    Mimura M; Kanatsuka A
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():169-74. PubMed ID: 9513409
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
    Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
    Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The activity of erythrocyte membrane enzymes in different stressor exposures].
    Maslova MN
    Fiziol Zh Im I M Sechenova; 1994 Jul; 80(7):76-80. PubMed ID: 7531085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endogenous Na+, K(+)-adenosine triphosphatase inhibitory factor in the regulation of membrane fluidity of erythrocytes in essential hypertension.
    Tsuda K; Shima H; Takeda J; Kimura K; Nishio I; Masuyama Y
    J Hypertens; 1992 Jul; 10(7):657-61. PubMed ID: 1321193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiological and physiopathological significance of endogenous digitalis-like factor in hypertension].
    Shibata H; Kojima I
    Nihon Rinsho; 1992 Apr; 50 Suppl():382-8. PubMed ID: 1321920
    [No Abstract]   [Full Text] [Related]  

  • 7. [A study of Na(+)-K(+)-ATP ase activity in erythrocyte membrane from diabetic retinopathy patients].
    He J; Qiu Y; Zhou X
    Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):421-3. PubMed ID: 11877243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D; Gallice P; Pouget J; Vague P
    Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the activity of Na+ K+ ATPase in erythrocytes and immunoreactive plasma digoxin-like substances in chronic renal insufficiency: their relation to blood pressure levels].
    Widimský J; Horký K; Lachmanová J; Dvoráková J
    Vnitr Lek; 1988 Sep; 34(9):843-50. PubMed ID: 2849244
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
    Balzan S; Montali U; Biver P; Ghione S
    J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endogenous digitalis-like substances].
    Zhu DL
    Sheng Li Ke Xue Jin Zhan; 1986 Oct; 17(4):333-7. PubMed ID: 3026044
    [No Abstract]   [Full Text] [Related]  

  • 13. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is there a relation between the presence in the serum of patients with arterial hypertension of a protein component with molecular weight of 15 kD and the inhibitory effect of the serum on Na,K-ATPase?].
    Rogaeva EA; Perova NV; Aleksandrov AA; Oganov RG; Lopina OD
    Vopr Med Khim; 1987; 33(4):34-9. PubMed ID: 2821695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Na(+)-K+ ATPase activity in uraemic adolescents.
    Vásárhelyi B; Sallay P; Balog E; Reusz G; Tulassay T
    Acta Paediatr; 1996 Aug; 85(8):919-22. PubMed ID: 8863871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the endogenous digitalis-like factor the link between hypertension and metabolic disorders as diabetes mellitus, obesity and acromegaly?
    Clerico A; Giampietro O
    Clin Physiol Biochem; 1990; 8(3):153-68. PubMed ID: 2225723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of intraerythrocytic Na+, K+, Ca++, Mg++ and cell-membrane Na+-K+-ATPase activities: its diagnostic value in digoxin poisoning].
    Wang JZ
    Zhonghua Yi Xue Za Zhi; 1987 Jul; 67(7):366-8. PubMed ID: 2822210
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endogenous digitalis-like factor].
    Ishii M; Goto A
    Nihon Rinsho; 1984 Sep; 42(9):2124-32. PubMed ID: 6097706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Natriuresis--the endogenous digoxin-like-factor and atrial natriuretic polypeptide].
    Goto A; Ishii M; Sugimoto T
    Nihon Rinsho; 1985 May; 43(5):914-22. PubMed ID: 2993704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.